IOLCP

IOL Chemicals and Pharmaceuticals Limited

Vertically integrated API and specialty chemicals manufacturer

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

iolcp.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹194.69
Market cap
5,699 Cr
Stock P/E
33.9
P/B
3.18
Dividend yield
0.5%
ROE (FY26)
7.7%
ROCE (FY26)
10.3%
Operating margin (FY26)
8.1%
Debt / equity (FY26)
0.07
OCF / EBITDA (FY26)
79.7%
OCF / EBITDA (3Y)
97.3%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

IOL Chemicals and Pharmaceuticals makes active pharmaceutical ingredients (APIs, the bulk drug substances used in medicines), anchored on ibuprofen, and industrial chemicals such as acetic anhydride and ethyl acetate, selling in India and overseas.

Company snapshot

58thBy market cap

Ranked among 119 companies in Pharmaceuticals.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 57.4% of revenue

SegmentRevenue shareRevenuePBTAssets
Chemical
52.6%
275 Cr5 Cr531 Cr
Pharmaceutical
57.4%
301 Cr26 Cr1,317 Cr
Unallocated
0.8%
4 Cr0 Cr458 Cr

Shares add up to 111% because segment revenues are before inter-segment eliminations.

What we see

Positives
  • ✓97% of operating profit came in as cash over the last three years — profits are backed by real cash.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales545 Cr520 Cr504 Cr502 Cr526 Cr523 Cr528 Cr552 Cr568 Cr580 Cr619 Cr756 Cr
Operating expenses (approx.)481 Cr476 Cr454 Cr451 Cr484 Cr476 Cr465 Cr490 Cr510 Cr523 Cr527 Cr653 Cr
EBITDA64 Cr44 Cr50 Cr51 Cr42 Cr47 Cr63 Cr62 Cr57 Cr57 Cr92 Cr103 Cr
OPM %11.8%8.5%9.8%10.2%7.9%9.0%11.9%11.3%10.1%9.9%14.9%13.7%
Other income7 Cr8 Cr8 Cr7 Cr6 Cr4 Cr5 Cr7 Cr7 Cr5 Cr2 Cr8 Cr
Interest4 Cr4 Cr3 Cr2 Cr4 Cr4 Cr4 Cr4 Cr3 Cr4 Cr3 Cr4 Cr
Depreciation16 Cr16 Cr16 Cr17 Cr18 Cr19 Cr19 Cr20 Cr20 Cr20 Cr20 Cr21 Cr
Profit before tax51 Cr32 Cr37 Cr40 Cr26 Cr28 Cr45 Cr46 Cr40 Cr28 Cr71 Cr87 Cr
Tax %26.0%28.1%25.8%24.2%26.2%26.2%29.7%25.4%26.0%25.3%24.9%25.7%
Net profit38 Cr23 Cr28 Cr30 Cr19 Cr21 Cr31 Cr34 Cr30 Cr21 Cr53 Cr64 Cr
EPS (₹)₹6.45₹3.93₹4.71₹5.11₹3.26₹3.50₹1.07₹1.16₹1.02₹0.70₹1.81₹2.20

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,184 Cr2,217 Cr2,133 Cr2,079 Cr2,319 CrSign in free for the trailing twelve months
Operating expenses (approx.)1,926 Cr1,991 Cr1,902 Cr1,877 Cr2,050 CrSign in free for the trailing twelve months
EBITDA258 Cr226 Cr231 Cr202 Cr269 CrSign in free for the trailing twelve months
OPM %11.8%10.2%10.8%9.7%11.6%Sign in free for the trailing twelve months
Other income32 Cr26 Cr30 Cr22 Cr21 CrSign in free for the trailing twelve months
Interest8 Cr16 Cr16 Cr15 Cr15 CrSign in free for the trailing twelve months
Depreciation43 Cr46 Cr63 Cr72 Cr80 CrSign in free for the trailing twelve months
Profit before tax225 Cr189 Cr182 Cr138 Cr184 CrSign in free for the trailing twelve months
Tax %25.4%26.2%26.0%26.7%25.3%Sign in free for the trailing twelve months
Net profit168 Cr139 Cr134 Cr101 Cr138 CrSign in free for the trailing twelve months
EPS (₹)₹28.56₹23.70₹22.90₹3.44₹4.69Sign in free for the trailing twelve months
Dividend payout %21.0%16.9%21.8%23.2%21.3%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital59 Cr59 Cr59 Cr59 Cr59 Cr
Reserves1,334 Cr1,449 Cr1,553 Cr1,629 Cr1,740 Cr
Borrowings44 Cr80 Cr33 Cr117 Cr132 Cr
Other liabilities526 Cr435 Cr600 Cr577 Cr656 Cr
Total liabilities1,962 Cr2,022 Cr2,244 Cr2,382 Cr2,587 Cr
Fixed assets (net)559 Cr751 Cr922 Cr1,158 Cr1,165 Cr
CWIP102 Cr81 Cr100 Cr21 Cr94 Cr
Investments2 Cr20 Cr20 Cr21 Cr21 Cr
Inventories410 Cr326 Cr425 Cr361 Cr371 Cr
Trade receivables470 Cr505 Cr471 Cr514 Cr603 Cr
Cash & bank4 Cr1 Cr8 Cr78 Cr65 Cr
Other assets415 Cr338 Cr299 Cr230 Cr267 Cr
Total assets1,962 Cr2,022 Cr2,244 Cr2,382 Cr2,587 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity93 Cr122 Cr290 Cr179 Cr214 Cr
Cash from investing-120 Cr-120 Cr-191 Cr-154 Cr-198 Cr
Cash from financing-2 Cr-4 Cr-92 Cr46 Cr-29 Cr
Net cash flow-29 Cr-2 Cr6 Cr70 Cr-13 Cr
Free cash flow (OCF − Capex)-60 Cr-90 Cr16 Cr-35 Cr41 Cr

Ratios

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %16.2%12.9%12.0%8.5%10.3%
ROE %12.0%9.2%8.3%6.0%7.7%
Debtor days7883819095
Inventory days94771089790
Days payable9474119115117
Cash conversion cycle7886697268
OCF / EBITDA %36.0%54.2%125.8%88.3%79.7%
OCF / EBITDA % (3 years)——70.7%89.7%97.3%
Debt / equity0.030.050.020.070.07
Current ratio2.112.022.001.891.78
Net debt / EBITDA0.160.350.110.190.25